Congratulations to Alexia Perryman for receiving the Society of Toxicology ToxScholar Outreach Grant to support her visit to California State University-East Bay (CSU-EB), where she served as an Invited Speaker for the “Introduction to Toxicology” undergraduate course. Alexia was hosted by the instructor, UNC CiTEM alumnus Brett Winters, and his students. Alexia presented on inhalation … Read more

Urban fires that destroy homes can be more toxic than wildfires that solely burn vegetation. Read more here!

Read about Dr. Ilona Jaspers’ path to success in a feature for International Day of Women and Girls in Science here!

Read more about the recipients here.

Exposure to woodsmoke particles before infection with SARS-CoV2 dampens antiviral gene expression in human nasal epithelial cells, especially in cells derived from females. These studies provide additional evidence that we need to consider how exposures to wildfire smoke could affect respiratory immune responses, particularly in the context of the current COVID-19 pandemic. Read more about … Read more

The UNC Center for Environmental Medicine, Asthma, and Lung Biology (CEMALB), under the Direction of Dr. Ilona Jaspers, was awarded a Cooperative Agreement with the Public Health & Integrated Toxicology Division laboratories of the U.S. Environmental Protection Agency (EPA) entitled “The Convergence Science in Environmental Health (COSINE) Program”. Read more about the Cosine Announcement!

Timothy Moran, MD, PhD, is a recent recipient of the NIEHS Outstanding New Environmental Scientist (ONES) Award. The objective of this 5-year, $2.68 million R01 research grant is to investigate how the indoor environment impacts peanut allergy development in children. Click here to read more!

The eRA Commons has selected Dr. Sophie Maiocchi’s K99 for funding and is currently in the administrative review process. Congrats Dr. Sophie Maiocchi!  

Thank you to our study coordinators Martha Almond, Noelle Knight, and Carole Robinette for their time and help with the clinical trial at UNC for molnupiravir, an oral pill, developed by Merck/Ridgeback, which was endorsed to treat COVID in the UK.

Meghan Rebuli, PhD, co-leader of the RETCC, won Young Investigator Award for the Society of Toxicology’s Inhalation and Respiratory Specialty Section